Cristin-resultat-ID: 1889145
Sist endret: 17. februar 2021, 10:09
NVI-rapporteringsår: 2020
Resultat
Vitenskapelig artikkel
2020

Development and evaluation of a method for concentration and detection of salmonid alphavirus from seawater

Bidragsytere:
  • Simon Chioma Weli
  • Lisa-Victoria Bernhardt
  • Lars Qviller
  • Mette Myrmel og
  • Atle Lillehaug

Tidsskrift

Journal of Virological Methods
ISSN 0166-0934
e-ISSN 1879-0984
NVI-nivå 1

Om resultatet

Vitenskapelig artikkel
Publiseringsår: 2020
Publisert online: 2020
Trykket: 2021
Artikkelnummer: 113990
Open Access

Importkilder

Scopus-ID: 2-s2.0-85094560900

Beskrivelse Beskrivelse

Tittel

Development and evaluation of a method for concentration and detection of salmonid alphavirus from seawater

Sammendrag

Waterborne viral infections represent a major threat to fish health. For many viruses, understanding the interplay between pathogens, host and environment presents a major hurdle for transmission. Salmonid alphavirus (SAV) can infect and cause pancreas disease (PD) in farmed salmonids in seawater. During infection, SAV is excreted from infected fish to the seawater. We evaluated two types of filters and four different eluents, for concentration of SAV3. One L of seawater was spiked with SAV3, followed by filtration and virus elution from membrane filters. For the negatively charged MF hydrophilic membrane filter (MF-) combined with NucliSENS® lysis buffer the SAV3 recovery was 39.5 ± 1.8 % by RT-ddPCR and 25.9 ± 5.7 % by RT-qPCR. The recovery using the positively charged 1 MDS Zeta Plus® Virosorb® membrane filter (MD+), combined with NucliSENS® lysis buffer was 19.0 ± 0.1 % by RT-ddPCR and 13.3 ± 3.8 % by RT-qPCR. The limits of quantification (LOQ) and detection (LOD) were estimated to be 5.18 × 103 and 2.0 × 102 SAV3 copies/L of natural seawater, by RT-ddPCR. SAV3 recovery from small volumes of seawater, and the requirement for standard laboratory equipment, suggest the MF-filter combined with NucliSENS® lysis buffer would be a candidate for further validation in experimental trials.

Bidragsytere

Simon Chioma Weli

  • Tilknyttet:
    Forfatter
    ved Fiskehelse og biosikkerhet ved Veterinærinstituttet

Lisa-Victoria Bernhardt

  • Tilknyttet:
    Forfatter
    ved Veterinærinstituttet
Aktiv cristin-person

Lars Qviller

  • Tilknyttet:
    Forfatter
    ved Epidemiologi ved Veterinærinstituttet

Mette Myrmel

  • Tilknyttet:
    Forfatter
    ved Institutt for parakliniske fag ved Norges miljø- og biovitenskapelige universitet
Inaktiv cristin-person

Atle Lillehaug

  • Tilknyttet:
    Forfatter
    ved Fiskehelse og biosikkerhet ved Veterinærinstituttet
1 - 5 av 5